Drug: prolastin (prolastin-c, ALPHA1-proteinase inhibitor) 1000MG/vial INJ, NDC #13533-0703-10, bulk funding for FY 2018
Ended Awarded Last action
- Contract number
- VA26018J2276
- Awardee
-
Grifols Therapeutics LLC UEI UFQ3A7GKJ5C7
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $193,111
Award facts
- Contract value 100% obligated
- $193,110.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$889 | |
| Funding Only Action | $2,000 | |
| Original award | $192,000 |
About this award
This federal contract award is for the drug Prolastin (Prolastin-C, alpha1-proteinase inhibitor) 1000mg/vial injection, with a National Drug Code (NDC) of 13533-0703-10. The contract, worth $193,110.72, was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 20 to Grifols Therapeutics LLC, a for-profit pharmaceutical manufacturer. The contract is a blanket purchase agreement (BPA) call order, with a firm fixed price pricing type. The contract period of performance is for Fiscal Year 2018, ending on September 30, 2018. The contract does not utilize any small business set-asides. Grifols Therapeutics LLC is a long-standing provider of pharmaceutical products, including Prolastin and immune globulin, to federal agencies such as the VA and the Defense Logistics Agency.
Quick answers
Who was awarded contract VA26018J2276?
VA26018J2276 was awarded to Grifols Therapeutics LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2017.
How much is contract VA26018J2276 worth?
The government has obligated $193,111 on VA26018J2276.
Is contract VA26018J2276 an order under another contract?
Yes. VA26018J2276 is a BPA call under V797D30042-VA797P13A0002, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA26018J2276 competed?
The extent of competition for VA26018J2276 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award